Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 4/20 | 0.40 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.40 |
| ▸ | KDM5A | P29375 | 1/20 | 0.38 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.38 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MPO | P05164 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CRHBP | P24387 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16861288 | 0.88 | SLC9A1 (0.37) | SLC9A1KDM5AKDM5BMPOCYP1A2 | |
| SCHEMBL13500287 | 0.87 | SLC9A1 (0.39) | SLC9A1KDM5AKDM5BMPOCYP1A2 | |
| Oxazole SCHEMBL27942106 | 0.87 | KDM5A (0.34) | SLC9A1TLR7KDM5AKDM5BTBXAS1 | |
| SCHEMBL19304399 | 0.85 | TLR7 (0.42) | TLR7KDM5AKDM5BTBXAS1TDP1 | |
| SCHEMBL3509109 | 0.84 | KDM5A (0.40) | TLR7KDM5AKDM5BTBXAS1TDP1 | |
| SCHEMBL16815457 | 0.84 | SLC9A1 (0.39) | SLC9A1KDM5AKDM5BTBXAS1MPO | |
| SCHEMBL8599492 | 0.81 | CYP3A4 (0.44) | TLR7KDM5AKDM5BTBXAS1TDP1 | |
| SCHEMBL4563226 | 0.80 | SLC9A1 (0.40) | SLC9A1TBXAS1TDP1MPOCYP1A2 | |
| SCHEMBL2494852 | 0.80 | SLC9A1 (0.36) | SLC9A1MPOCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL21217018 | 0.79 | TLR7 (0.43) | TLR7KDM5AKDM5BTBXAS1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 794 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220057416-A1 | METHOD FOR OPTIMIZATION OF CANNABIS DOSAGE AND MIXTURE OF ACTIVE CANNABINOIDS | THSEE LLC (US) | 2022-02-24 | — | — | US | claimed |
| CN-113045498-A | 1, 5-diaryl pyrazole derivative, synthesis method and application | 江苏食品药品职业技术学院 | 2021-06-29 | — | — | CN | claimed |
| WO-2020132691-A1 | METHOD FOR OPTIMIZATION OF CANNABIS DOSAGE AND MIXTURE OF ACTIVE CANNABINOIDS | THSEE, LLC (US) | 2020-06-25 | — | — | WO | claimed |
| US-9326967-B2 | Vaporizable cannabinoid compositions | PERRY STEPHEN C (US) | 2016-05-03 | — | — | US | claimed |
| US-20100298622-A1 | APPARATUSES AND TECHNIQUES FOR BIOACTIVE DRUG DELIVERY IN THE PROSTATE GLAND | VANCE WASEET | 2010-11-25 | — | — | US | claimed |
| US-20070225544-A1 | APPARATUSES AND TECHNIQUES FOR BIOACTIVE DRUG DELIVERY IN THE PROSTATE GLAND | VANCE WASEET | 2007-09-27 | — | — | US | claimed |
| WO-2007098443-A2 | APPARATUSES AND TECHNIQUES FOR BIOACTIVE DRUG DELIVERY IN THE PROSTATE GLAND | VANCE WASEET (US) | 2007-08-30 | — | — | WO | claimed |
| EP-1752149-A1 | CB1 Antagonists or inverse agonists as therapeutical agents for the treatment of inflammation involving gene expression | LABORATORIOS DEL DR. ESTEVE, S.A. (ES) | 2007-02-14 | — | — | EP | claimed |
| WO-2004055211-A2 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING NEURODEGENERATIVE PATHOLOGIES | EXONHIT THERAPEUTICS SA (FR) | 2004-07-01 | — | — | WO | claimed |
| JP-5320137-A | — | — | None | — | — | JP | disclosed |
| US-20240226124-A9 | CANNABIDIOL FOR TREATING NEURODEGENERATIVE DISEASES | AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240189329-A1 | WATER-SOLUBLE CANNABIS CANNABINOID SYSTEMS FOR INFUSING PRODUCTS WITH NANOEMULSIONS HAVING NANOSCALE SIZES | HEXO OPERATIONS INC. (CA) | 2024-06-13 | — | — | US | disclosed |
| EP-4373483-A1 | COMBINATION OF A KETONE BODY OR KETOGENIC COMPOUND WITH AN ANALGESIC OR ANTIOXIDANT | KetoSwiss AG (CH) | 2024-05-29 | — | — | EP | disclosed |
| US-20240148896-A1 | HYDROGEL PRODRUG FOR TREATMENT | VIKING SCIENTIFIC, INC. | 2024-05-09 | — | — | US | disclosed |
| EP-0534800-A2 | Regioselective synthesis of 1,5-diaryl pyrazole anti-inflammatory agents | ORTHO PHARMACEUTICAL CORPORATION (US) | 1993-03-31 | — | — | EP | disclosed |
| EP-0534800-A2 | Regioselective synthesis of 1,5-diaryl pyrazole anti-inflammatory agents | ORTHO PHARMACEUTICAL CORPORATION (US) | 1993-03-31 | — | — | EP | disclosed |
| US-5117054-A | Chemical intermediate for antiinflammatory agents | ORTHO PHARMACEUTICAL CORPORATION (US) | 1992-05-26 | — | — | US | disclosed |
| US-5117054-A | Chemical intermediate for antiinflammatory agents | ORTHO PHARMACEUTICAL CORPORATION (US) | 1992-05-26 | — | — | US | disclosed |
| EP-0248594-A2 | Pharmacologically active 1,5-diaryl-3-substituted-pyrazoles and method for synthesizing the same | ORTHO PHARMACEUTICAL CORPORATION (US) | 1987-12-09 | — | — | EP | disclosed |
| CN-87103953-A | Pharmaceutically active 1, 5-diaryl-3-substituted pyrazoles and synthesis method thereof | — | 1987-12-09 | — | — | CN | disclosed |